tiprankstipranks
Agile Therapeutics (AGRX)
NASDAQ:AGRX
US Market

Agile Therapeutics (AGRX) Financial Statements

1,492 Followers

Agile Therapeutics Financial Overview

Agile Therapeutics's market cap is currently ―. The company's EPS TTM is $-13.097; its P/E ratio is -0.03; Agile Therapeutics is scheduled to report earnings on March 28, 2024, and the estimated EPS forecast is $-0.92. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 6.66M$ 3.20M$ 3.81M$ 4.00M$ 3.00M
Gross Profit$ 4.18M$ 3.20M$ 1.81M$ 2.34M$ 1.58M
EBIT$ -458.00K$ -3.44M$ -4.99M$ 18.64M$ -18.66M
EBITDA$ -360.00K$ -3.34M$ -4.89M$ 18.73M$ -18.40M
Net Income Common Stockholders$ -799.00K$ -3.81M$ -5.39M$ 18.24M$ -19.67M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.87M$ 2.79M$ 4.43M$ 5.25M$ 6.14M
Total Assets$ 10.89M$ 12.57M$ 13.70M$ 14.24M$ 18.46M
Total Debt$ 2.14M$ 2.19M$ 2.22M$ 2.21M$ 2.15M
Net Debt$ -735.00K$ -593.00K$ -2.21M$ -3.04M$ -4.00M
Total Liabilities$ 23.30M$ 24.69M$ 23.13M$ 19.79M$ 12.20M
Stockholders Equity$ -12.41M$ -12.12M$ -9.43M$ -5.54M$ 6.26M
Cash Flow-
Free Cash Flow$ 365.00K$ -8.52M$ -1.59M$ -1.56M$ -16.70M
Operating Cash Flow$ 365.00K$ -8.52M$ -1.59M$ -1.56M$ -16.70M
Investing Cash Flow----$ 0.00
Financing Cash Flow$ 1.38M$ 6.88M$ 778.00K$ 660.00K$ 9.82M
Currency in USD

Agile Therapeutics Earnings and Revenue History

Agile Therapeutics Debt to Assets

Agile Therapeutics Cash Flow

Agile Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis